How HIV research drives health innovation in multiple diseases
Nat Med
.
2025 Dec;31(12):3965-3967.
doi: 10.1038/s41591-025-04019-5.
Authors
Lawrence Corey
1
2
3
,
Jirair Ratevosian
4
,
Chris Beyrer
4
,
Judith Currier
5
,
Joseph Eron
6
,
Myron S Cohen
6
,
Steven G Deeks
7
Affiliations
1
Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA. lcorey@fredhutch.org.
2
Department of Medicine, University of Washington, Seattle, WA, USA. lcorey@fredhutch.org.
3
Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA, USA. lcorey@fredhutch.org.
4
Duke Global Health Institute, Duke University, Durham, NC, USA.
5
University of California at Los Angeles, Los Angeles, CA, USA.
6
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
7
University of California at San Francisco, San Francisco, CA, USA.
PMID:
41136629
DOI:
10.1038/s41591-025-04019-5
No abstract available
Grants and funding
UM1 AI068614/AI/NIAID NIH HHS/United States
UM1AI068636/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
UM1AI068619/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
UM1 AI068614/AI/NIAID NIH HHS/United States